Long, Meiying
Li, Jianxu
He, Meiling
Qiu, Jialin
Zhang, Ruijun
Liu, Yingchun
Liang, Chunfeng
Lu, Haiyan
Pang, Yadan
Zhou, Hongmei
Yu, Hongping
Qiu, Moqin
Funding for this research was provided by:
Self-Raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Z20201371)
Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital (2021-10)
Guangxi Universities Training Program of Young Teachers (2022KY0079)
Key Research and Development Project of Guangxi (AA18221001, AA18221001)
Natural Science Foundation of Guangxi Province (2018GXNSFDA050012, 2018GXNSFDA050012)
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University, Guangxi Medical University)
Ministry of Education (GKE-KF202007 and GKE-ZZ202118)
Article History
Received: 9 October 2022
Accepted: 29 May 2023
First Online: 7 June 2023
Declarations
:
: The study protocol was approved and reviewed (Approval Number: LW2022119) by the Ethics Committee of the Center of Guangxi Medical University Cancer Hospital. Patients who participated in the study had signed written informed consent.
: Not applicable.
: The authors declare no competing interests.